Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

377 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
74 Ge( n , γ ) cross section below 70 keV measured at n_TOF CERN.
Lederer-Woods C, Aberle O, Andrzejewski J, Audouin L, Bécares V, Bacak M, Balibrea J, Barbagallo M, Barros S, Battino U, Bečvář F, Beinrucker C, Berthoumieux E, Billowes J, Bosnar D, Brugger M, Caamaño M, Calviño F, Calviani M, Cano-Ott D, Cardella R, Casanovas A, Castelluccio DM, Cerutti F, Chen YH, Chiaveri E, Colonna N, Cortés G, Cortés-Giraldo MA, Cosentino L, Damone LA, Diakaki M, Domingo-Pardo C, Dressler R, Dupont E, Durán I, Fernández-Domínguez B, Ferrari A, Ferreira P, Finocchiaro P, Furman V, Göbel K, García AR, Gawlik-Ramięga A, Glodariu T, Gonçalves IF, González-Romero E, Goverdovski A, Griesmayer E, Guerrero C, Gunsing F, Harada H, Heftrich T, Heinitz S, Heyse J, Jenkins DG, Jericha E, Käppeler F, Kadi Y, Katabuchi T, Kavrigin P, Ketlerov V, Khryachkov V, Kimura A, Kivel N, Kokkoris M, Krtička M, Leal-Cidoncha E, Leeb H, Lerendegui-Marco J, Meo SL, Lonsdale SJ, Losito R, Macina D, Marganiec J, Martínez T, Massimi C, Mastinu P, Mastromarco M, Matteucci F, Maugeri EA, Mendoza E, Mengoni A, Milazzo PM, Mingrone F, Mirea M, Montesano S, Musumarra A, Nolte R, Oprea A, Patronis N, Pavlik A, Perkowski J, Porras I, Praena J, Quesada JM, Rajeev K, Rauscher T, Reifarth R… See abstract for full author list ➔ Lederer-Woods C, et al. Among authors: duran i. Eur Phys J A Hadron Nucl. 2022;58(12):239. doi: 10.1140/epja/s10050-022-00878-5. Epub 2022 Dec 9. Eur Phys J A Hadron Nucl. 2022. PMID: 36514540 Free PMC article.
Pharmaceutical cost savings from the treatment of oncology patients in clinical trials.
Gómez Mediavilla B, Lanza León P, Martínez Callejo V, Cantarero Prieto D, Lanza Postigo M, Salcedo Lambea M, Blanco Mesonero Y, Ochagavia Sufrategui M, Durán I, Sarabia Cobo CM. Gómez Mediavilla B, et al. Among authors: duran i. Biomed J. 2024 Apr 26:100742. doi: 10.1016/j.bj.2024.100742. Online ahead of print. Biomed J. 2024. PMID: 38679197
RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain.
Badiola LB, Milagro NL, Lavín DC, Peraita SL, Ibarbia MA, Kareaga MM, Fernández Del Rivero TP, Otero DSP, López VA, Fernández CÁ, Emborujo AL, Arnaiz IG, Rodríguez RF, Sagastibeltza N, Duran I; GONORTE Collaborative Group. Badiola LB, et al. Among authors: duran i. Semin Oncol. 2024 Mar 4:S0093-7754(24)00005-8. doi: 10.1053/j.seminoncol.2024.02.002. Online ahead of print. Semin Oncol. 2024. PMID: 38604897
Measurement of the ^{140}Ce(n,γ) Cross Section at n_TOF and Its Astrophysical Implications for the Chemical Evolution of the Universe.
Amaducci S, Colonna N, Cosentino L, Cristallo S, Finocchiaro P, Krtička M, Massimi C, Mastromarco M, Mazzone A, Maugeri EA, Mengoni A, Roederer IU, Straniero O, Valenta S, Vescovi D, Aberle O, Alcayne V, Andrzejewski J, Audouin L, Babiano-Suarez V, Bacak M, Barbagallo M, Bennett S, Berthoumieux E, Billowes J, Bosnar D, Brown A, Busso M, Caamaño M, Caballero-Ontanaya L, Calviño F, Calviani M, Cano-Ott D, Casanovas A, Cerutti F, Chiaveri E, Cortés G, Cortés-Giraldo MA, Damone LA, Davies PJ, Diakaki M, Dietz M, Domingo-Pardo C, Dressler R, Ducasse Q, Dupont E, Durán I, Eleme Z, Fernández-Domínguez B, Ferrari A, Furman V, Göbel K, Garg R, Gawlik-Ramięga A, Gilardoni S, Gonçalves IF, González-Romero E, Guerrero C, Gunsing F, Harada H, Heinitz S, Heyse J, Jenkins DG, Junghans A, Käppeler F, Kadi Y, Kimura A, Knapová I, Kokkoris M, Kopatch Y, Kurtulgil D, Ladarescu I, Lederer-Woods C, Leeb H, Lerendegui-Marco J, Lonsdale SJ, Macina D, Manna A, Martínez T, Masi A, Mastinu P, Mendoza E, Michalopoulou V, Milazzo PM, Mingrone F, Moreno-Soto J, Musumarra A, Negret A, Nolte R, Ogállar F, Oprea A, Patronis N, Pavlik A, Perkowski J, Petrone C, Piersanti L, Pirovano E, Porras I, Praena J, … See abstract for full author list ➔ Amaducci S, et al. Among authors: duran i. Phys Rev Lett. 2024 Mar 22;132(12):122701. doi: 10.1103/PhysRevLett.132.122701. Phys Rev Lett. 2024. PMID: 38579210
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
Powles T, Valderrama BP, Gupta S, Bedke J, Kikuchi E, Hoffman-Censits J, Iyer G, Vulsteke C, Park SH, Shin SJ, Castellano D, Fornarini G, Li JR, Gümüş M, Mar N, Loriot Y, Fléchon A, Duran I, Drakaki A, Narayanan S, Yu X, Gorla S, Homet Moreno B, van der Heijden MS; EV-302 Trial Investigators. Powles T, et al. Among authors: duran i. N Engl J Med. 2024 Mar 7;390(10):875-888. doi: 10.1056/NEJMoa2312117. N Engl J Med. 2024. PMID: 38446675 Clinical Trial.
Health-related Quality of Life in Patients with Previously Treated Advanced Urothelial Carcinoma from EV-301: A Phase 3 Trial of Enfortumab Vedotin Versus Chemotherapy.
Rosenberg JE, Mamtani R, Sonpavde GP, Loriot Y, Duran I, Lee JL, Matsubara N, Vulsteke C, Castellano D, Sridhar SS, Pappot H, Gurney H, Bedke J, van der Heijden MS, Galli L, Keam B, Masumori N, Meran J, O'Donnell PH, Park SH, Grande E, Sengeløv L, Uemura H, Skaltsa K, Campbell M, Matsangou M, Wu C, Hepp Z, McKay C, Powles T, Petrylak DP. Rosenberg JE, et al. Among authors: duran i. Eur Urol. 2024 Feb 27:S0302-2838(24)00008-3. doi: 10.1016/j.eururo.2024.01.007. Online ahead of print. Eur Urol. 2024. PMID: 38418343 Free article.
Criteria and indicators to evaluate quality of care in genitourinary tumour boards.
Puente J, Algaba Arrea F, Buisán Rueda Ó, Castellano Gauna D, Durán I, Fernández Ávila JJ, Gómez-Iturriaga A, Parada Blázquez MJ, Pérez Fentes D, Sancho Pardo G, Vallejo Casas JA, Gratal P, Pardo MT, Guillem Porta V. Puente J, et al. Among authors: duran i. Clin Transl Oncol. 2024 Feb 11. doi: 10.1007/s12094-024-03381-z. Online ahead of print. Clin Transl Oncol. 2024. PMID: 38341809
377 results